Indegene
Helps global healthcare organizations address complex challenges by seamlessly integrating analytics and technology. Learn more
Launch date
Employees
Market cap
CAD3.0b
Enterprise valuation
CAD2.9b (Public information from Sep 2024)
Share price
INR641.40002 INDGN.NS
Woodbridge Township New Jersey (HQ)
Financials
Estimates*
INR | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 9.7b | 16.6b | 23.1b |
% growth | - | 72 % | 39 % |
EBITDA | 2.6b | 3.1b | 4.4b |
% EBITDA margin | 27 % | 18 % | 19 % |
Profit | 1.5b | 1.6b | 2.7b |
% profit margin | 15 % | 10 % | 12 % |
Date | Investors | Amount | Round |
---|---|---|---|
$200m Valuation: $700m | Growth Equity VC | ||
* | $6.5m Valuation: $1.5b 6.6x EV/LTM Revenues 36.0x EV/LTM EBITDA | Secondary | |
* | N/A | N/A | IPO |
Total Funding | CAD273m |
Related Content
Recent News about Indegene
EditMore about Indegene
EditWe are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare organizations to be future ready.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Indegene
EditACQUISITION by Indegene Apr 2016
ACQUISITION by Indegene Dec 2016
ACQUISITION by Indegene Dec 2016
ACQUISITION by Indegene Aug 2021
ACQUISITION by Indegene Nov 2006
ACQUISITION by Indegene Mar 2024
ACQUISITION by Indegene Oct 2022